Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bright Prospects for Micromet and Medimmune (Part 2)
Seeking Alpha
Friday, April 24, 2009 - 11:01am
tags:
Micromet, MedImmune
Is Teva's CEO the most influential drug exec?
Fierce Pharma
Friday, April 24, 2009 - 10:36am
tags:
Teva Pharmaceuticals, Pharma CEOs
Drug stocks follow broader market north
Marketwatch
Friday, April 24, 2009 - 10:34am
tags:
drug stocks
Roche To Start New Trial With Tarceva In Lung Cancer
WSJ Online
Friday, April 24, 2009 - 10:02am
tags:
Roche, Tarceva, drug trials, lung cancer
Is Dendreon a $360 Stock - Or Is That Too Low?
Seeking Alpha
Friday, April 24, 2009 - 10:01am
tags:
Dendreon, Provenge
Abbott Laboratories: Dividend Stock Analysis
Seeking Alpha
Friday, April 24, 2009 - 9:59am
tags:
Abbott Laboratories
Illumina, Inc (ILMN): Zacks Rank Buy
Yahoo/Zacks.com
Friday, April 24, 2009 - 8:38am
tags:
Illumina
GSK Slides Away From Innovation
InVivo
Friday, April 24, 2009 - 8:33am
tags:
GSK, dermatology
King Pharma CEO's pay falls by nearly half in 2008
Yahoo/AP
Friday, April 24, 2009 - 8:18am
tags:
King, Brian Markison, Pharma CEOs
Pfizer shareholders back advisory vote on exec pay
Yahoo/AP
Friday, April 24, 2009 - 8:16am
tags:
Pfizer
Can Merck Maintain Its Profitability as a Low Cost Drug Producer?
Seeking Alpha
Friday, April 24, 2009 - 8:11am
tags:
Merck
Why I Doubt the FDA Will Approve Acorda's Fampridine
Seeking Alpha
Friday, April 24, 2009 - 6:14am
tags:
Acorda Therapeutics, FDA, Fampiridine, antihypertensives
Amgen Profit Falls, Misses Estimates
TheStreet.com
Friday, April 24, 2009 - 6:12am
tags:
Amgen, earnings
FDA Extends Bristol Diabetes Drug Deadline
TheStreet.com
Friday, April 24, 2009 - 6:11am
tags:
FDA, diabetes, Bristol-Myers Squibb, Onglyza
The Next Cancer Bestseller?
Forbes
Friday, April 24, 2009 - 6:10am
tags:
Novartis, Gleevec, leukemia, kidney cancer, Afinitor
Worldwide, consumers prefer generics, says study
Medical Marketing and Media
Thursday, April 23, 2009 - 10:07am
tags:
generics
FDA, Clinical Trial Calendar Updates: Acorda, Alkermes, GTx
Seeking Alpha
Thursday, April 23, 2009 - 10:04am
tags:
FDA, drug trials, Acorda Therapeutics, GTx, Alkermes
U.S. Drug Sales Projected to Decline This Year
WSJ Online
Thursday, April 23, 2009 - 9:50am
tags:
drug sales
FDA Calendar Updates: Diabetes
Seeking Alpha
Thursday, April 23, 2009 - 9:48am
tags:
FDA, diabetes, Bristol-Myers Squibb, AstraZeneca, Onglyza, alogliptin, Takeda, Novo Nordisk, Victoza
Solvay: Yes, we're reviewing our strategies
Fierce Pharma
Thursday, April 23, 2009 - 9:27am
tags:
Solvay

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.